Growth Metrics

Integra Lifesciences Holdings (IART) Retained Earnings (2016 - 2026)

Integra Lifesciences Holdings' Retained Earnings history spans 17 years, with the latest figure at -$30.1 million for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 103.2% to -$30.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$30.1 million, a 103.2% decrease, with the full-year FY2025 number at -$30.1 million, down 103.2% from a year prior.
  • Retained Earnings hit -$30.1 million in Q4 2025 for Integra Lifesciences Holdings, down from $425.1 million in the prior quarter.
  • Over the last five years, Retained Earnings for IART hit a ceiling of $943.6 million in Q1 2024 and a floor of -$50.0 million in Q2 2021.
  • Historically, Retained Earnings has averaged $228.3 million across 5 years, with a median of -$11.3 million in 2022.
  • Biggest five-year swings in Retained Earnings: tumbled 1512.68% in 2021 and later skyrocketed 52649.63% in 2024.
  • Tracing IART's Retained Earnings over 5 years: stood at -$45.2 million in 2021, then surged by 2046.89% to $879.1 million in 2022, then plummeted by 101.72% to -$15.1 million in 2023, then skyrocketed by 6322.13% to $939.9 million in 2024, then tumbled by 103.2% to -$30.1 million in 2025.
  • Business Quant data shows Retained Earnings for IART at -$30.1 million in Q4 2025, $425.1 million in Q3 2025, and -$30.9 million in Q2 2025.